SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is a trending topic as anticipation grows for its potential PMDA approval in Japan and its presentation at the J.P. Morgan Healthcare Conference, driving significant community discussion. Investors are actively highlighting the company's innovative Alpha DaRT technology and recent strong clinical data in pancreatic cancer, signaling a potential shift towards increased institutional interest in this transformative oncology player.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to CEO Diane Garrett's recent FoxTV interview, continuous share accumulation by billionaire investor Eric Sprott, and promising high-grade silver drill results, all against a backdrop of surging silver prices. The community is actively discussing massive upside potential and a potential short squeeze, fueled by Sprott's buying and the company's vast untapped resources. Conversely, a vocal skeptical faction highlights the lack of active mining, dilution risks, and perceived overvaluation, warning of an eventual market correction.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing a sharp stock decline, sparking widespread investor confusion despite recent financial reports indicating better-than-expected performance. The immediate catalyst appears to be market apprehension regarding the debt impact of its substantial acquisition ambitions and a temporary halt in share buybacks. This has divided the community, with many seizing what they call a 'generational' buying opportunity, while others foresee deeper corrections due to perceived growth moderation and sector competition.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as escalating geopolitical tensions, particularly surrounding potential US tariffs on European countries over Greenland, drive a significant 'risk-off' rotation in the markets. The community is actively discussing gold as a premier safe-haven asset, anticipating continued strong upside as investors seek protection against market instability and potential fiat currency debasement. This robust demand is pushing the metal to new highs amidst broader concerns over the US dollar and global economic conditions.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing a sharp downturn as natural gas prices surge due to "mega bullish" cold weather forecasts and an anticipated "short squeeze" in long natural gas positions. The community is actively debating whether to buy KOLD on its significant dip, anticipating a potential reversal in what many perceive as overbought natural gas. Traders are navigating extreme volatility and the inherent decay of these leveraged ETFs, closely watching for further shifts in weather patterns and market sentiment for this "widowmaker" commodity.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals (CRVS) is trending following its announcement of strong Phase 1 clinical trial data for soquelitinib in atopic dermatitis, showcasing high efficacy and a favorable safety profile that excites investors about its blockbuster potential. While the positive results have fueled significant bullish sentiment and speculation around partnerships, a recently announced public offering has simultaneously introduced dilution concerns, leading to mixed community perspectives.

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Anteris Technologies Global Corp.

Anteris Technologies Global

Anteris Technologies (AVR) is trending following news of a significant public offering coupled with a strategic private placement where Medtronic agreed to acquire a substantial stake, alongside the initiation of its pivotal PARADIGM trial for the DurAVR heart valve. While some investors are expressing concerns about share dilution, a strong bullish sentiment persists within the community, citing institutional interest and the potential for a major re-rating given the advanced stage of its medical device technology.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending following positive FDA guidance requiring no new trials for its ANKTIVA sBLA, with resubmission expected within 30 days, signaling a clear path for label expansion in bladder cancer. The community is highly optimistic about this de-risked pathway, alongside significant international approvals like Saudi Arabia's for NSCLC, fueling strong discussions of a potential short squeeze and the company's broader impact on cancer treatment.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amid significant business developments, including an expanded multi-year, multi-hundred-million-dollar deal with HD Hyundai and prominent features at Davos showcasing its AI platform's efficiency. Community discussion is polarized between excitement over its AI-driven revenue growth and skepticism concerning its high valuation, alongside recent controversial reports about its work with government agencies like ICE. The company's unique position at the intersection of AI, government, and enterprise continues to fuel intense debate on its ethical implications and future growth trajectory.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is trending following an investor day that revealed significantly raised revenue guidance and prompted numerous analyst price target upgrades, signaling strong confidence in its future trajectory. The community is actively discussing the company's robust position in autonomous systems, anticipating a substantial run fueled by potential defense contracts and strategic acquisitions. Despite broader market volatility, investors view recent dips as buying opportunities, reinforcing the long-term growth outlook in critical defense and communication infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating

Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating PR Newswire...

<ul class="summary-bullets"><li>The acquisition includes $20 million in cash and about 11.1 million USAS common shares.</li><li>To fund the cash portion, USAS entered into a “bought deal” private placement with Canaccord Genuity Corp. and BMO Capital Markets.</li><li>USAS plans to launch a five-year drilling program beginning in 2026.</li></ul>&nbsp;Americas Gold and Silver Corp. (USAS) announced on Thursday that it signed a binding agreement to acquire 100% of Crescent Silver, LLC, owner of the Crescent Mine in Idaho, for around $65 million.The acquisition includes $20 million in cash and about 11.1 million USAS common shares, valued at roughly $45 million based on a price of $4 per share.In addition to containing high-grade silver, the Crescent mine also contains copper and antimony.To fund the cash portion, USAS entered into a “bought deal” private placement with Canaccord Genuity Corp. and BMO Capital Markets to raise gross proceeds of $65 million through equity financing.The fully permitted Crescent Mine holds a high-grade historical mineral resource totaling 22.9 million ounces (Moz) of silver across categories. Based on prior studies, the mine could add 1.4 - 1.6 Moz of annual silver output, while also increasing the company’s exposure to antimony.&nbsp;Its close proximity to Galena complex offers operational advantages, including shared processing, infrastructure, and workforce efficiencies.&nbsp;With less than 5% of the property explored, Americas plans to launch a five-year drilling program beginning in 2026.“Significant parts of the mine have yet to be drilled and we expect to target these with a US$3.5 million drill program commencing in 2026. While the near-term development at Crescent is potentially accretive to our silver and antimony resources, we are excited to test these areas to evaluate the strong potential for mine-life extension,” said Paul Andre Huet, Chairman and CEO.Stock WatchDespite the acquisition update, <a href="https://stocktwits.com/symbol/USAS">USAS stock</a> fell 9.4%.The stock has also remained in the ‘bearish’ territory over the past 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:919/97;" src="https://news.stocktwits-cdn.com/USAS_png_fde2c602c9.webp" alt="USAS.png" width="919" height="97"><figcaption>USAS' Sentiment Meter and Message Volumes on November 13, 2025 | Source: Stocktwits</figcaption></figure>USAS shares have seen significant buying interest so far this year, gaining more than 320%.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, one-ounce American Silver Eagle bullion coin is placed among one-ounce silver bullion coins

Americas Gold And Silver To Acquire Crescent Silver For $65 Million

In addition to high-grade silver, the Crescent mine also contains copper and antimony.

Equity

USAS Boosts Mine Efficiency With Galena No. 3 Shaft's Phase 1 Upgrades

Americas Gold and Silver completes Phase 1 upgrades at Galena No. 3 Shaft, boosting hoisting capacity and advancing its growth strategy.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$6.93
Prev Close	$6.48
Open	$6.88
Dividend Yield	0.00%
50-Day Moving Average	$5.00
Beta	1.14
Avg. Volume	4.17M
PE Ratio	-25.09

52-Week High	$6.94
52-Week Low	$0.9913
Market Capitalization	$1.9B
EPS (Annual)	-$0.4241
Price to Book	37.75
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

USAS
Americas Silver Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest USAS News

USASAmericas Silver Corp